Skip to content

Clinical trials

Completed Brain Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Status: Completed Country / region: United Kingdom Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20122
20131
20142
20151
20163
20172
20191
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.3
Imperial College London2
TauRx Therapeutics Ltd2
AC Immune SA1
Eli Lilly and Company1
Guy's and St Thomas' NHS Foundation Trust1
Inmune Bio, Inc.1
Olympic Medical1
ReNeuron Limited1
University College Cork1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases16
Central Nervous System Diseases5
Nervous System Diseases5
Seizures5
Alzheimer Disease4
Dementia4
Epilepsy4
Epilepsies, Myoclonic3
Neurodegenerative Diseases3
Asphyxia Neonatorum2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.